ATE261737T1 - Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten - Google Patents

Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten

Info

Publication number
ATE261737T1
ATE261737T1 AT00981499T AT00981499T ATE261737T1 AT E261737 T1 ATE261737 T1 AT E261737T1 AT 00981499 T AT00981499 T AT 00981499T AT 00981499 T AT00981499 T AT 00981499T AT E261737 T1 ATE261737 T1 AT E261737T1
Authority
AT
Austria
Prior art keywords
viral infections
contain
pharmaceutical preparations
cardiac glycoside
loop diuretic
Prior art date
Application number
AT00981499T
Other languages
English (en)
Inventor
Christopher Edward Hartley
Original Assignee
Henderson Morley Res & Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9930811.6A external-priority patent/GB9930811D0/en
Priority claimed from GB0000683A external-priority patent/GB0000683D0/en
Priority claimed from GB0023198A external-priority patent/GB0023198D0/en
Application filed by Henderson Morley Res & Dev Ltd filed Critical Henderson Morley Res & Dev Ltd
Application granted granted Critical
Publication of ATE261737T1 publication Critical patent/ATE261737T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Eyeglasses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT00981499T 1999-12-30 2000-12-13 Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten ATE261737T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9930811.6A GB9930811D0 (en) 1999-10-15 1999-12-30 Anti-viral treatment
GB0000683A GB0000683D0 (en) 1999-10-15 2000-01-12 Antiviral treatment
GB0023198A GB0023198D0 (en) 1999-12-30 2000-09-21 Treatment of DNA viral infections
PCT/GB2000/004793 WO2001049242A2 (en) 1999-12-30 2000-12-13 Combinations for the treatment of dna viral infections comprising a loop diuretic cardiac glycoside

Publications (1)

Publication Number Publication Date
ATE261737T1 true ATE261737T1 (de) 2004-04-15

Family

ID=27255465

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00981499T ATE261737T1 (de) 1999-12-30 2000-12-13 Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten

Country Status (17)

Country Link
US (1) US6894030B2 (de)
EP (1) EP1242119B1 (de)
JP (1) JP2003519163A (de)
KR (1) KR100843790B1 (de)
CN (1) CN1414863A (de)
AT (1) ATE261737T1 (de)
AU (1) AU777339B2 (de)
BR (1) BR0016831A (de)
CA (1) CA2395016C (de)
DE (1) DE60009146T2 (de)
DK (1) DK1242119T3 (de)
ES (1) ES2218254T3 (de)
IL (1) IL150286A0 (de)
MX (1) MXPA02006489A (de)
PT (1) PT1242119E (de)
TR (1) TR200401363T4 (de)
WO (1) WO2001049242A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
GB2376628B (en) * 2001-06-19 2005-06-08 Henderson Morley Res & Dev Ltd Treatment of DNA viral infections in cats
ATE435019T1 (de) * 2000-09-21 2009-07-15 Henderson Morley Res & Dev Ltd Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung
GB2367242B (en) * 2000-09-21 2004-07-28 Henderson Morley Res & Dev Ltd Antiviral treatment
US7534768B2 (en) * 2000-12-13 2009-05-19 Henderson Morely Research And Development Ltd. Treatment of DNA viral infections
WO2003099011A1 (en) * 2002-05-28 2003-12-04 Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
DE10223932A1 (de) * 2002-05-29 2003-12-18 Rudolf Wank Verwendung von Diuretika zur Behandlung von Schwellungen
MXPA05008527A (es) 2003-02-12 2006-03-08 Univ Georgetown Uso de artemisinina para tratar tumores inducidos por virus oncogenicos y para tratar infecciones virales.
GB2413282B (en) * 2004-04-23 2009-01-14 Henderson Morley Plc DNA Viral Infections
GB0517838D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Transdermal active principle delivery means
GB0517840D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Topical anti viral formulations
JP2009511629A (ja) * 2005-10-17 2009-03-19 ニューロセラピューティクス ファーマ， インコーポレイテッド 中枢神経系疾患の調節に有用な利尿薬様化合物類似体
GB0616451D0 (en) * 2006-08-18 2006-09-27 Henderson Morley Plc Dna viral infections
CN106562982A (zh) * 2016-09-27 2017-04-19 苏州系统医学研究所 强心苷类化合物在抗埃博拉病毒感染中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03240732A (ja) * 1990-02-14 1991-10-28 Yasuo Tanaka 抗ウイルス剤
US7071230B2 (en) * 1997-10-02 2006-07-04 Board Of Trustees Of Southern Illinois University Therapeutic use of D-methionine to reduce the toxicity of noise
WO2000010574A1 (en) * 1998-08-24 2000-03-02 Hadasit Medical Research Services And Development Ltd. The use of loop diuretics for hiv infection
ATE306275T1 (de) * 1999-12-30 2005-10-15 Henderson Morley Res & Dev Ltd Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten

Also Published As

Publication number Publication date
EP1242119A2 (de) 2002-09-25
WO2001049242A3 (en) 2002-07-11
IL150286A0 (en) 2002-12-01
CN1414863A (zh) 2003-04-30
DE60009146T2 (de) 2005-02-17
CA2395016A1 (en) 2001-07-12
KR20030005162A (ko) 2003-01-17
US20030050253A1 (en) 2003-03-13
TR200401363T4 (tr) 2004-08-23
AU1873401A (en) 2001-07-16
PT1242119E (pt) 2004-08-31
CA2395016C (en) 2009-04-14
DE60009146D1 (de) 2004-04-22
MXPA02006489A (es) 2003-09-22
AU777339B2 (en) 2004-10-14
JP2003519163A (ja) 2003-06-17
EP1242119B1 (de) 2004-03-17
KR100843790B1 (ko) 2008-07-03
WO2001049242A2 (en) 2001-07-12
ES2218254T3 (es) 2004-11-16
DK1242119T3 (da) 2004-08-02
US6894030B2 (en) 2005-05-17
BR0016831A (pt) 2002-09-10

Similar Documents

Publication Publication Date Title
DE60009146D1 (de) Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DE69830728D1 (de) Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz
ATE276245T1 (de) Indolderivate und deren verwendung zur behandlung von u.a. osteoporosis
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
EE200300504A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
ATE298339T1 (de) ß3,7-DIAZABICYCLO(3.3.0)OCTANE UND DEREN VERWENDUNG BEI DER BEHANDLUNG VON HERZRHYTHMUSSTÖRUNGENß
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
DE69916488D1 (de) Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren
ATE306275T1 (de) Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten
WO1999056666A8 (en) The treatment of sexual dysfunction in certain patient groups
EE200300495A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
EE200300506A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
DE69325512D1 (de) Verwendung von remacemid zur behandlung des morbus parkinson
ATE196424T1 (de) Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten
DE69825307D1 (de) Verwendung von protein h als zytostattischer wirkstoff
DE69932741D1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
ATE165508T1 (de) Verwendung von 2-methylamino-2-phenylcyclohexanon zur behandlung von infektionen und zur immunmodulation
PT958290E (pt) Derivados de 1,4-di-hidropiridina e seu uso em terapia
FR2652502B1 (fr) Agent anti-virus du sida et medicaments therapeutiques ou preventifs utilisant cet agent.
DE58902466D1 (de) Acyl-carnitin zur behandlung und zur verhuetung von virusinfektionen.
RU99101388A (ru) Способ лечения флеботромбоза в области закрытых переломов костей
DE50000562D1 (de) Mittel zur behandlung von pigmentierungsstörungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1242119

Country of ref document: EP